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ABSTRACT
Bone mineral density (BMD) achieved during young adulthood (peak BMD) is one of the major determinants of osteoporotic fracture in
later life. Genetic variants associated with BMD have been identified by three recent genome-wide association studies. The most
significant single-nucleotide polymorphisms (SNPs) from these studies were genotyped to test whether they were associated with peak
BMD in premenopausal American women. Femoral neck and lumbar spine BMD were determined by dual-energy X-ray absorptiometry
in two groups of premenopausal women: 1524 white women and 512 black women. In premenopausal white women, two SNPs in the
C6orf97/ESR1 region were significantly associated with BMD (p<4.8 10
 4), with suggestive evidence for CTNNBL1 and LRP5 (p<.01).
Evidence of association with one of the two SNPs in the C6orf97/ESR1 region also was observed in premenopausal black women.
Furthermore, SNPs in SP7 and a chromosome 4 intergenic region showed suggestive association with BMD in black women. Detailed
analyses of additional SNPs in the C6orf97/ESR1 region revealed multiple genomic blocks independently associated with femoral neck
and lumbar spine BMD. Findings in the three published genome-wide association studies were replicated in independent samples of
premenopausal American women, suggesting that genetic variants in these genes or regions contribute to peak BMD in healthy women
in various populations.  2010 American Society for Bone and Mineral Research.
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Introduction
O
steoporosis is a common skeletal disease characterized by
reduced bone mineral density (BMD). After the age of 50
years, the lifetime risk of osteoporotic fractures is approximately
40% in white American women and 14% in white American
men.
(1) A major predictor of future osteoporotic fracture risk is
peak BMD obtained during early adulthood.
(2) Although
attainment of peak BMD is determined by both genetic and
environmental components, twin and family studies indicate
that genetic factors account for up to 80% of normal variation in
BMD.
(3)
Recent genome-wide association studies have identified
single-nucleotide polymorphisms (SNPs) associated with
BMD.
(4–6) Several of the associated genes, such as the estrogen
receptor 1 (ESR1), low-density lipoprotein–related protein 5 (LRP5),
and osteoprotegerin (OPG), have well-characterized roles in
skeletal biology. However, these studies also have identified
novel genes that were not known previously to affect BMD but
may play an important role in bone accrual or loss.
The three genome-wide association studies were published at
the start of the current study. They were performed on the
Framingham family sample of approximately equal proportions
ofmenandwomen,
(4)aUKtwinsampleofonlywomen,
(5)andan
Icelandic sample consisting of over 85% women.
(6) However,
sinceall three sampleshada meanagegreater than 50 years,the
associations identified may reflect a combination of age-related
bone loss and peak BMD. Thus the aim of this study was to
replicate the most significant SNPs identified in these three
studies in samples of premenopausal women.
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1821Subjects and Methods
Sample
Families with two or more healthy premenopausal sisters were
recruited from the state of Indiana to identify genes contributing
to bone mass. These provided a sample of 1524 American white
and 512 American black women (Table 1). A detailed medical
history of the siblings was obtained through administration of
health and lifestyle questionnaires. Parents of the siblings were
recruitedtoobtainbloodforDNAextractionbutdidnotundergo
phenotypic assessment. Studies were performed at the Indiana
Clinical Research Center. The study was approved by the
Institutional Review Board of Indiana University–Purdue Uni-
versity Indianapolis. Informed written consent was obtained
from all subjects prior to their participation in the study.
Sisters were between the ages of 20 and 51 years. Sisters were
required to be premenopausal and within 10 years of each other
in age. Women who had irregular menses or a history of
pregnancy or lactation within 3 months prior to enrollment were
excluded. Women taking oral contraceptives were not excluded.
Additionalexclusioncriteriaincludedahistoryofchronicdisease,
use of medications known to affect bone mass or metabolism,
and an inability to have BMD measured because of obesity.
BMD, height, and weight measurements
Areal BMD (g/cm
2) at the lumbar spine (vertebrae L2 to L4) and
femoral neck was measured by dual-energy X-ray absorptio-
metry (DXA) using two DPX-L and one Prodigy instrument (GE
Lunar Corp., Madison, WI, USA). All three instruments were cross-
calibrated weekly using a step-wedge phantom. There was no
detectable systematic difference between the three machines
over the course of the study. The coefficient of variation on
duplicate measurements after repositioning the subject was
1.0% for femoral neck and 0.52% for lumbar spine. Siblings
were measured on the same instrument usually at the same
visit. Height and weight were measured using a Harpenden
stadiometer (Holtain Ltd., Crymych, UK) and a Scale-Tronix
(White Plains, NY, USA) weighing scale, respectively.
SNP Genotyping
The most significant SNPs for replication were selected from the
three published genome-wide association studies available at
the time this study was initiated. The top 25 SNPs for lumbar
spine BMD and the top 25 SNPs for femoral neck BMD were
selected from the studies of the TwinsUK cohort
(5) and an
Icelandic sample.
(6) Since the genome-wide association study
from the Framingham Heart Study reported association results
using both men and women,
(4) we selected the 20 most
significantly associated SNPs each for femoral neck and lumbar
spine BMD from a reanalysis of these data in only women
(www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id¼
phs000007.v5.p3). This secondary analysis was performed to
maximize the likelihood of identifying genes that affect BMD
in women. Because 6 of the 140 SNPs were significant in
both BMD phenotypes, 134 unique SNPs were tested for
replication.
WhenanSNPfailedtoworkingenotypingassays,anotherSNP
was selected as a replacement using the genotypic information
of the CEPH Utah sample in HapMap. The criteria for selection of
the replacement SNP was the closest SNP in physical distance to
the original SNP (and always within 20kb), strong linkage
disequilibrium (r
2>0.5) with the original SNP, and minor allele
frequency within 0.1 of the original SNP. When no SNPs met
these criteria, then the SNP with the highest r
2 was chosen from
allSNPswithin20kb.ThecompletelistofSNPstestedisprovided
in Supplemental Table 1.
GenotypingwasperformedusingtheiPLEXgenotypingassays
on the MassARRAY platform, which is based on allele-specific
primer extension with mass-modified terminators (Sequenom,
Inc., San Diego, CA, USA). The average missing rate for the
genotyping assays was 2.1%, with a range from 0.6% to 8.2%
(Supplemental Table 1). Using one randomly selected individual
in each family, each SNP was tested for significant (p<.001)
deviation from Hardy-Weinberg equilibrium. In addition, par-
ental genotypes were used to identify Mendelian inconsistencies
using the program PedCheck.
(7) Inconsistent genotypes were
reviewed individually, and the minimum number of genotypes
was removed to resolve the Mendelian inconsistencies.
Genome-wide association data
A genome-wide association study was completed recently in the
same sample of 1524 premenopausal white sisters.
(8) Thus, for
those regions where the previous associations were replicated,
the data were augmented with those generated by the genome-
wide association study.
Genotyping was performed on the Human610Quadv1_B
(Illumina, San Diego, CA, USA) by the Center for Inherited
Disease Research (CIDR) using the Illumina Infinium II assay
protocol. Genotype calls were made when a genotype yielded a
quality metric (Gencall score) of 0.15 or higher. Blind duplicate
reproducibility was99.99% based on 36 paired samples. Samples
having genotypes for at least 98% of the SNPs were included in
the analyses. Our final analytic sample included 1524 women
from 762 different families. This data set demonstrated minimal
evidence of stratification, as indicated by a lack of inflation in
genome-wide association study p values (l¼1.003) for both the
spine and neck BMD phenotypes.
SNPs with a call rate of 98% or greater (n¼581,255) were
included and subjected to further quality-control analyses. From
these, SNPs were removed if either the minor allele frequency
was less than 0.01 in this data set (n¼32,948) or there was
significant deviation (p<.00001) from Hardy-Weinberg
Table 1. Sample Characteristics
White women Black women
Number of families 762 236
Number of sibling subjects 1524 512
Age, years
a 33.1 7.2 33.0 6.6
Height, cm
a 165.4 6.1 164.4 6.2
Weight, kg
a 70.0 16.6 81.9 19.8
Lumbar spine BMD, g/cm
2a 1.275 0.141 1.339 0.142
Femoral neck BMD, g/cm
2a 1.021 0.136 1.110 0.145
aMean SD.
1822 Journal of Bone and Mineral Research ICHIKAWA ET AL.equilibrium (n¼1998). The final data set for analysis consisted of
547,971 SNPs that passed all quality-control measures.
Statistical analysis
In these samples of women, age and weight were significant
covariates of BMD.
(9,10) Therefore, regression residuals represent-
ing age- and weight-adjusted BMD values for each subject were
computed separately in white women and black women and
used in all analyses.
A population-based association test was performed using a
linear regression framework. SNP genotypes were modeled as
takingonthreelevels (0,1, and2)corresponding tothe observed
genotypes, with BMD as the dependent variable. This model was
fitted using the qfam-total analysis in PLINK.
(11) Correlation
between siblings in the same family was corrected for by
obtaining empirical p values for the association test using a
permutation approach.
(10) Permuted replicates were generated
by randomly assigning phenotype values among family
members, thus preserving the phenotypic correlations and
linkage disequilibrium structure from one replicate to another.
p Values were estimated empirically using 10
5 permutations.
The significance threshold for the association tests was
derivedusingthesimpleMmethod.
(12,13)TheeffectiveSNPcount
for this set of SNPs based on our genotype data was 105,
providing a corrected threshold for significant association p
value of 4.8 10
 4. p Values less than .01 were considered
suggestive evidence of association. Effect size estimates
correcting for sibling correlation were obtained using a
mixed-model approach.
For genes or chromosomal regions with SNPs showing
replication in white women, the data set was augmented with
SNPs from our genome-wide association study to allow more
rigorous evaluation of the association. The haplotype block
structurewasexaminedwithHAPLOVIEW,
(14)withblocksdefined
using the method of Gabriel and colleagues.
(15) Linkage
disequilibrium confidence interval parameters of (0.5, 0.75)
were employed, with recombination and informative fraction
values of 0.5 and 0.75, respectively. Rates of recombination were
determined as described previously.
(16) The blocks then were
examined regarding their independent and combined effect on
BMD, as measured by the traditional r
2 measure of proportion of
phenotypic variance explained.
Results
Replication of published genome-wide association
studies
White and black women were comparable in age and height
(Table 1). However, black women were heavier than white
womenandhadhigherBMDvaluesatboththefemoralneckand
the lumbar spine. In these samples, 129 of the 134 possible SNPs
from the three published genome-wide association studies
(4–6)
had a greater than 90% call rate and were analyzed for
association with BMD (Supplemental Table 1). Two SNPs,
rs1406493 and rs10496481, were not in Hardy-Weinberg
equilibrium (p<.001).
Five chromosomal regions associated with BMD in the three
genome-wide association studies showed evidence of associa-
tion (p<.01) (Table 2). However, only SNPs in a region harboring
C6orf97 and ESR1 reached significance level corrected for
multiple testing. Only rs851993 in ESR1 was replicated in both
white and black premenopausal women. The study design had
Table 2. Replication of Significant SNPs Identified in the Previous Genome-wide Association Studies
SNP Gene
b Chr. Position Chr
White women Black women
MAF
d
Femoral neck Lumbar spine
MAF
d
Femoral neck Lumbar spine
p Value r
2 p Value r
2 p Value r
2 p Value r
2
rs4870044 C6orf97 151,943,102 6 0.30 5.6 10
 4 1.21%
rs6929137 C6orf97 151,978,370 6 0.34 3.8 10
 3 0.25%
rs7752591 C6orf97 151,988,761 6 0.46 2.9T10
 4 0.11% 2.2 10
 3 0.72%
rs6900157 C6orf97 151,995,820 6 0.36 7.6 10
 3 0.01% 3.2 10
 3 0.86%
rs851993 ESR1 152,047,704 6 0.36 2.6 10
 3 0.40% 3.3T10
 4 0.40% 0.12 4.5T10
 4 0.67%
rs3020331 ESR1 152,050,473 6 0.42 3.7 10
 3 1.24%
rs851982 ESR1 152,066,678 6 0.38 8.9 10
 3 1.29%
rs4811196 CTNNBL1 35,903,108 20 0.19 6.9 10
 4 0.61%
rs2179320 CTNNBL1 35,905,199 20 0.19 3.0 10
 3 0.57%
rs910760 CTNNBL1 35,933,409 20 0.25 1.8 10
 3 0.21%
rs3736228 LRP5 67,957,871 11 0.13 4.5 10
 3 0.40%
rs10876432
(rs2886129
a)
SP7 52,018,251 12 0.45 6.6 10
 3 3.99% 5.3 10
 3 5.00%
rs6535028 Intergenic 135,757,169 4 0.14 8.0 10
 3 1.18%
aSNP genotyped as a replacement.
bThe nearest genes located within 25kb.
cChromosome positions are from NCBI dbSNP Build 130.
dRace-specific minor allele frequencies (MAFs).
ep Values and r
2 are shown only for SNPs with p<.01. p Values that met the corrected significance level of p<4.8 10
 4 are in boldface.
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in the white sample and 2.3% in the black sample.
White women
The sample of white women replicated association in three
different regions. Seven SNPs in a 125-kb region that included
neighboring C6orf97 and ESR1 were associated with BMD
(p<.01). However, only two SNPs (rs7752591 and rs851993) met
a more stringent level of significance (p<4.8 10
 4). All but
rs6929137 in C6orf97 were associated with lumbar spine BMD,
and four SNPs were associated with femoral neck BMD. The
estimated effect size on lumbar spine and femoral neck BMD for
each SNP individually was no more than 1.3%.
A nonsynonymous LRP5 SNP (rs3736228) was marginally
associated with lumbar spine BMD (p¼4.5 10
 3). Three SNPs
in CTNNBL1 also showed suggestive evidence of association with
femoral neck BMD (p 3.0 10
 3). These three SNPs, spanning
30kb, were in high linkage disequilibrium (r
2>0.66).
Black women
One SNP (rs851993) in the C6orf97/ESR1 region that also
replicated in the white women had the most significant
association with femoral neck BMD in black women
(p¼4.5 10
 4). In addition, one SNP in SP7 (rs2886129) on
chromosome12showedsuggestiveevidenceofassociationwith
both femoral neck (p¼6.6 10
 3) and lumbar spine BMD
(p¼5.3 10
 3). An intergenic SNP (rs6535028) on chromosome
4 was marginally associated with femoral neck BMD
(p¼8.0 10
 3). None of the SNPs in the CTNNBL1 or LRP5
region replicating in the sample of white women demonstrated
evidence of association with either BMD phenotype in black
women (p>.01).
Supporting evidence from our genome-wide association
study
For the three regions associated in the sample of white women,
data from our genome-wide association study
(8) were reviewed
to assess whether there was further support for the association.
CTNNBL1
Four additional SNPs from our genome-wide association study
supported evidence of the association between femoral neck
BMD and CTNNBL1 (Fig. 1). The region harboring associated SNPs
spanned about100kb.The mostsignificantSNPs werelocatedin
Fig. 1. Evidence of association in the CTNNBL1 region. Arrows indicate the size and location of the genes. Circles (femoral neck) and triangles (lumbar
spine) denote SNPs tested in white women in our replication study (black) and genome-wide association study (gray). Association results (top panel) are
indicatedby chromosomal locationonthex axisand–logofpvalueson they axis.Thresholdofp¼.01is markedby thedashedline.Theextentoflinkage
disequilibrium (r
2) structure (bottom panel) is represented by the degree of shading. Darker shades indicate greater linkage disequilibrium.
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about 0.20 to 0.25.
LRP5
In addition to the association with lumbar spine BMD, there was
an association between femoral neck BMD and two SNPs located
in the 5’ end of the gene (Fig. 2). Two SNPs in the neighboring
SAPS3 gene also were associated with lumbar spine BMD. These
SNPs were in moderate linkage disequilibrium with the
replicated LRP5 SNP (rs3736228).
C6orf97/ESR1
A total of 170 SNPs spanning 622kb around C6orf97 and ESR1
were genotyped in our genome-wide association study. Thirty-
three SNPs spanning 346kb provided evidence of association
with BMD (Fig. 3). Closer examination of the association, allele
frequency, recombination, and linkage disequilibrium data
uncovered a complex pattern of association in this region.
Based on the linkage disequilibrium and recombination rate, this
region can be divided into four distinct genomic blocks
independently associated with femoral neck and/or lumbar
spine BMD.
The block most distal to ESR1 (ie, within C6orf97) was defined
by SNPs rs9371528 and rs6925996, and 13 SNPs in this block all
were associated with lumbar spine BMD. The most significant
SNP in this block was rs6925996 (p¼1.1 10
 4), which had an
MAF of 0.31; it had moderate to high linkage disequilibrium with
all the associated SNPs in this block.
The second block, marked by SNPs rs900195 and rs851993,
showed a complex pattern of association. Thirteen SNPs were
associated with either lumbar spine or femoral neck BMD, and
four of those were associated with both phenotypes. SNP
rs7752591, located in the center of the block, was the most
significant SNP for femoral neck BMD (p¼7.0 10
 5), whereas
the SNP most proximal to ESR1 (rs851993) was most significant
for lumbar spine BMD (p¼2.2 10
 4). Both SNPs also were
associated with the other phenotype.
The block between SNPs rs9383939 and rs2504065 (block 3) is
adjacent to block 2 and extended from immediately upstream of
the long isoform of ESR1 to its intragenic region. Six SNPs in this
blockwereassociated withlumbar spine BMD; twoof these SNPs
also were associated with femoral neck BMD. All associated SNPs
in this block, except one, were relatively common, with MAFs of
0.34 to 0.50. The most significantly associated SNPs with lumbar
spine and femoral neck BMD were rs3020331 (p¼4.1 10
 3)
and rs851991 (p¼1.3 10
 3), respectively.
Fig. 2. Evidence of association in the LRP5 region. Arrows indicate the size and location of the genes. Circles (femoral neck) and triangles (lumbar spine)
denoteSNPstestedinwhitewomeninourreplicationstudy(black)andgenome-wideassociationstudy(gray).Associationresults(toppanel)areindicated
by chromosomal location on the x axis and –log of p values on the y axis. Threshold of p¼.01 is marked by the dashed line. The extent of linkage
disequilibrium (r
2) structure (bottom panel) is represented by the degree of shading. Darker shades indicate greater linkage disequilibrium.
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rs9322336, was located at the beginning of the main ESR1
isoform. Only one SNP (rs1709183) was associated with femoral
neck BMD (p¼1.3 10
 3) and had an MAF of 0.29.
The most significant SNPs in each block provided evidence of
independenteffectsonBMD(Fig.4).ThemostsignificantSNPsin
each block had little linkage disequilibrium with the most
significant SNPs in other blocks (r
2<0.4 for spine BMD, r
2<0.2
for neck BMD; Table 3). In block 1, the more frequent allele was
associatedwithincreasedlumbarspineBMD,whereasinblocks2
and 3, the minor allele was associated with increased BMD.
Similarly, in blocks 2 and 4, the minor allele was associated with
high femoral neck BMD, whereas in block 3, the major allele was
associated with increased BMD. Furthermore, when analyzed
jointly, these SNPs explained a significantly greater proportion of
BMD variability than each SNP did individually. Each SNP had a
relatively small effect size (1.5% or less); however, when analyzed
jointly, the simultaneous 3-SNP effect was essentially additive,
with the individual SNP summed effect sizes accounting for 71%
and 84% of the combined effect on spine and neck BMD,
respectively (Table 3). Nonindependent effects would be
expected to produce a summed effect much larger than the
combinedeffect.Ourresultsindicatethattheeffectofeachblock
(and SNPs within) is largely independent of one another.
A more detailed analysis of these blocks uncovered the fact
that even the associated SNPs within the same block had only
moderate linkage disequilibrium (r
2) owing to significant
differences in MAF (data not shown). Even when two physically
overlapping groups of SNPs had similar MAFs, they sometimes
had little linkage disequilibrium with each other. Thus it is
possible that each block has ‘‘subblocks’’ that may affect BMD
independently.
Fig. 3. Evidence of association in the C6orf97/ESR1 region. Arrows indicate the size and location of the genes. Circles (femoral neck) and triangles (lumbar
spine) denote SNPs tested in white women in our replication study (black) and genome-wide association study (gray). Association results (top panel) are
indicated by chromosomal location on the x axis and –log of p values on the left y axis. Threshold of p¼.01 is marked by the dashed line. Peaks indicate
historic recombination in this region. Recombination rates are shown on the right y axis. The extent of linkage disequilibrium structures (middle, D’ and
bottom, r
2) is represented by the degree of shading. Darker shading indicates stronger correlation between SNPs. Blocks based on linkage disequilibrium
are represented by inverted triangles. The chromosomal regions corresponding to these blocks are marked by colored horizontal lines (top panel).
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In this study we sought to replicate findings from the three
published genome-wide association studies
(4–6) in our samples
of white and black women, who are significantly younger than
those in the original studies. Multiple genes/regions were
replicated in our sample, indicating that genetic variants in these
genes/regions contribute to peak BMD in the general female
population. Most of the replicated associations were observed in
our white women sample. This is most likely so because the
sample of white women was substantially larger than that of
black women and therefore had greater power to detect
association. In addition, the initial associations were reported in
white cohorts consisting primarily of women, and some of the
Fig. 4. Comparison of mean BMD as a function of SNP genotypes. The most significant SNP for lumbar spine and femoral neck BMD was selected from
eachofthefourdifferentblocksinFig.3.Genotypesandcorrespondingsamplenumbers(inparentheses)areonthexaxis;meanBMD SEM(g/cm
2)ison
the y axis.
Table 3. Additive Effects of the Most Significant SNPs From Separate Blocks
SNP
Observed effect
size (r
2)
Expected effect
size (r
2)
Linkage
disequilibrium (D’)
Linkage
disequilibrium (r
2)
Lumbar spine
rs6925996 rs851993 rs3020331 2.18% 3.08%
rs6925996 rs851993 1.82% 2.14% 0.363 0.035
rs6925996 rs3020331 1.82% 2.07% 0.263 0.024
rs851993 rs3020331 1.43% 1.94% 0.675 0.356
rs6925996 1.13%
rs851993 1.00%
rs3020331 0.94%
Femoral neck
rs7752591 rs851991 rs1709183 2.52% 3.01%
rs7752591 rs851991 1.73% 2.28% 0.353 0.108
rs7752591 rs1709183 2.08% 2.07% 0.005 0
rs851991 rs1709183 1.75% 1.68% 0.025 0
rs7752591 1.34%
rs851991 0.94%
rs1709183 0.73%
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women was smaller than that of white women, resulting in
decreased power to detect significant association. However,
some of the previously reported associations also were
associated in the sample of black women, suggesting that
some genes may contribute to variation in BMD across multiple
ethnic groups.
Detailed analysis of the C6orf97/ESR1 region demonstrated a
complex pattern of association. There were four linkage
disequilibrium blocks independently associated with lumbar
spine or femoral neck, suggesting the presence of multiple
geneticfactors affecting peakBMD.Sincemany oftheassociated
SNPs were located upstream of ESR1, these factors likely regulate
expression of ESR1. This association pattern is in agreement with
the previous genome-wide association study in the Icelandic
sample, in which the associated SNPs spanning 273kb were
distributed over several linkage disequilibrium blocks, and many
of the SNPs had modest to minimal linkage disequilibrium.
(6) A
similar pattern also was observed in a study of several cancer
types, where five haplotype blocks on chromosome 8q24 were
associated with the risk of different cancers.
(17) These data
suggestthathigh-densitySNPgenotypingisessentialtouncover
intricate association patterns because there may be multiple
SNPs affecting expression of a gene.
Many of the replicated SNPs are located in or near ESR1, LRP5,
and SP7, genes that have known function in bone. The
importance of ESR1 and LRP5 in bone biology is clear from
Mendelian disorders caused by mutations in these genes,
(18–21)
meta-analyses of association studies for skeletal pheno-
types,
(22,23) and phenotypes of genetically modified mice.
(24,25)
Although our sample of black women is smaller than the white
sample (and thus the effect size is likely inflated), the association
between BMD and the SNP in SP7 (osterix) supports its candidate
gene status as an important regulator of osteoblast differentia-
tion.
(26) Of note, the same SNP was marginally associated with
femoral neck BMD in white women (p¼3.6 10
 2), and osterix
also was identified in the recent genome-wide association study
in a sample of UK children.
(27) Thus this study confirms the
observed associations with these genes and further strengthens
their roles in determination of peak bone mass in young
adulthood.
On the other hand, the major advantage of genome-wide
association studies is the ability to identify novel genes without a
priori knowledge of gene functions. In this regard, CTNNBL1,
encoding a protein homologous with b-catenin,
(28) is one such
gene that has no known role in bone biology. Expression of this
gene was detected by RT-PCR in all 24 human tissues and cell
lines, including bone and osteosarcoma cell lines, MG-63, and
SaOS-2 (data not shown). In a yeast two-hybrid system,
(29) it also
interacts with secreted phosphoprotein 1 (osteopontin), which
has a known function in bone remodeling. Although association
with the SNPs located in C6orf97 is likely due to linkage
disequilibrium with adjacent ESR1, involvement of this open-
reading frame in bone cannot be ruled out at present. Similarly,
suggestive evidence of association with the intergenic SNP on
chromosome 4 should not be overlooked because SNPs like
this will provide an opportunity to identify novel genes or
regulatory elements including microRNAs. Molecular investiga-
tions targeting these genes and regions may open up avenues
for new drug targets for osteoporosis.
We have analyzed the white and black women separately
because of the documented differences in allele frequency at
many of the SNPs considered, along with the BMD differences
between the two cohorts. Based on the genome-wide associa-
tion study,
(8) data in the whites are not stratified and are unlikely
to produce false-positive associations. To assess the evidence
for stratification in our black American sample, we used an
admixture covariate derived from principal-component analysis
of genotypes at 145 SNPs that we have genotyped previously
compared with HapMap controls (YRI and CEU). This analysis
demonstrated no appreciable difference in the p values for the
black American association findings reported and enabled us to
rule out stratification as a contributor to the results reported
here.
The consistent findings across independent samples of
women provide further evidence that the genes or regions
replicated are important in determining BMD. The results of this
study also showed that certain genes affect both postmeno-
pausal and premenopausal women, suggesting that some genes
may act across a wide age range. Alternatively, some of these
genes may exert their effects on peak BMD, but the evidence of
their effects may persist into older ages. On the other hand, the
fact that many of the previously identified regions did not
replicate suggests that some of these regions may affect age-
related bone loss rather than peak BMD. A further study is
necessary to distinguish genetic effects on bone mass and loss.
In summary, we determined that significant SNPs identified
in three recent genome-wide association studies also were
associated with peak BMD in healthy white and black American
women. Replication of the previous genome-wide association
studies indicates that variants in ESR1, LRP5, and SP7 affect peak
BMD in healthy women and suggests that novel genes such as
CTNNBL1 may have a role in attainment or maintenance of peak
BMD. Similar replication studies in more recent genome-wide
association studies
(27,30,31) are likely to identify additional
variants important across multiple ethnicities.
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